2025 SPEAKERS
Mohamed Abdillahi, Senior Director, Risk Management, AstraZeneca
Adel Abou Ali, VP, Global Risk Management and REMS Strategy, Syneos Health
Maria Abou Samra, Safety Officer, Genethon
Howard Abroms, VP, Global Business Development, Soterius, Inc.
Ana Sofia Afonso, Director, Pharmacoepidemiology, Global Patient Safety, Eli Lilly
Indy Ahluwalia, Senior Managing Consultant, Eliquent Life Sciences
Vivek Ahuja, Executive Vice President, Pharmacovigilance, Eversana
Gaetano Aiello, Senior Manager, PV System Excellence, Jazz Pharmaceuticals
Omar Aimer, Executive Member of ISoP and NASoP President, International Society of Pharmacovigilance (ISoP)
Stefanie Amend-Mall, Director, Patient Safety HUB Europe, Sandoz
Maria Skou Andersen, Director of Veeva Center of Excellence, ProductLife Group
Sheela Ankolekar, Associate Director, Senior Pharmacovigilance Physician, Norgine Ltd
Julia Appelskog, Head of QPPV Office and PV Intelligence, CSL
Felix Arellano, Senior Vice President, Global Head of Safety and Risk Management, Roche
Simon Ashworth, Global Head of Safety, Menarini
Ercem Atillasoy, Chief Regulatory and Safety Officer, Jazz Pharmaceuticals
Erin Austin, Vice President, PV Services, Nextrove
Mina G Awad, Pharmacovigilance Senior Manager and QPPV, Middle East, Kyowa Kirin International
Tea Babic, Director, Head of PV Audits and Inspections, Deputy Head PV Compliance, Teva Pharmaceuticals
Jamal Baig, Director, Pharmacovigilance, Country Safety Head, Sanofi
Ikram Baig, CEO, Quartica
Bogdana Ioana Balas, Group Medical Director, Late-Stage & Marketed Medicines Safety, Roche
Marianne Banoub, Regional Head of PV and QA, NewBridge Pharmaceutical
Erika Barbarosie, Associate Director, Compliance, Pharmaceuticals
Tiago Barca Ramos, Director, Compliance & Process Excellence, GCSP, Swiss QPPV, Bavarian Nordic
Zoltán Barna, Head, Global PV Compliance, Gedeon Richter Plc
Iain Barnden, PV Business Partner, Digital Innovation, Cencora
Agnès Barrere, Local QPPV (RPV), France, Otsuka Pharmaceutical
Judy Barretto, Senior Director, Virology TA, Patient Safety, Gilead
Eniko Barta Kondas, Head, Global PV Operations, Gedeon Richter Plc
Erica Bavol, Senior Director, Head of Safety Operations, Compliance and Systems, Corcept
Lisa Benaise, Head of Global Pharmacovigilance, Miltenyi Biotec
Blanca Berrocal Gonzalez, Head of Pharmacovigilance Compliance, Veterinary Medicines Directorate
Delphine BERTRAM, Senior Director, EU QPPV, Pharming
Kapil Bhutada, Senior Director, Safety Operations and Compliance, Medical Safety & Pharmacovigilance, AskBio
Alex Bica, Global Head of Early Development Safety, CSL Behring
Mariette Boerstoel, Senior Vice President, Worldwide Patient Safety Officer, Bristol Myers Squibb
Laura Paola Boga, Senior Director, Head of Global Pharmacovigilance, UK & EU QPPV, Dompé farmaceutici spa
Chris Bone, Director, Safety and Benefit Risk, Biogen
Aurelia Bordes, Corporate Vice President, Safety Operations, Parexel International LLC
Ronald Boumans, Independent Medical Devices Expert, EU Medical Devices Expert
Barbara Bovy, Director, Head of Quality Intelligence, UCB
Michael Braun-Boghos, Senior Director, Safety Strategy, Oracle Health and Life Sciences
Jason Bryant, Senior Vice President, Product Management - AI, ArisGlobal
Siva Kumar Buddha, Medical Director, Global Patient Safety, Amgen
Carolina Buitrago, Medical Director, Global Patient Safety, AstraZeneca & Alexion
Sean Burke, Executive Director, Regional Lead, International Pharmacovigilance, MSD
Gloria Bustos, Global Head Global Patient Safety, Vantive
Janice Byrd, Director, Global Patient Safety Vendor Oversight, BeOne Medicines
Pedro Caetano, Senior Safety Physician, Debiopharm International
Mattia Calissano, Vice President, Medical, SSI Strategy
Natacha Carragher, Senior Advisor, Pharmacoepidemiology, Global Patient Safety, Eli Lilly
Mark Cawley, Associate Director, R&D Procurement, Jazz Pharmaceuticals
Nicola Charpentier, Vice President, Head of Benefit Risk Management, Medical Safety and Pharmacovigilance, BioNTech
Mijal Chavda, Senior Director, Global Head of GxP Inspections & GVP Quality, Kyowa Kirin International
Pawel Chomiak, Associate Director, Clinical Data Management, MSD
David Chonzi, Independent Pharma Physician, Independent PV Expert
Rishi Chopra, Executive Director, Head of International Pharmacovigilance (IPV) & Global PV Operations (GPVO), CSL
MUGDHA Chopra, Co-founder and Director, AWINSA Life Sciences
Mircea Ciuca, Former AVP, Head Global Medical Safety, Independent PV Expert
Jan Cleerbout, Deputy QPPV, Johnson & Johnson Innovative Medicine
CLAIRE COLPIN, Lead Safety Officer, Genethon
Chrissa Cooper, Director, Pharmacovigilance, Norgine Ltd
Galina Cordero, Head of Pharmacovigilance Department, QPPV, JSC Farmak
Juan Daccach, Vice President, Global Product Safety, Merz Aesthetics
Aytek Dağistanli, CEO, DeltaPV
Mark Daniels, Senior Medical Director, Medical Safety, Jazz Pharmaceuticals
Michelle Motta Dardeno, Vice President, Head of Global Patient Safety, Aurinia
Dr. Jay Dave, Technical Director, Global Patient Safety & Risk Management, COD Research Pvt LTD
Suranjan De, Vice President, Client Relations & Product Innovation, RxLogix
Anthonius (Ton) de Boer, Chairman, CBG-MEB Medicines Evaluation Board
Jolanda De Bruijne, Senior Director, Head of PV Compliance, Teva Pharmaceuticals
Fabio De Gregorio, Vice President, Head of Drug Safety Europe, Shionogi BV
Martin de Kort, Scientific Lead Medicines Development, EATRIS ERIC
Peter De Veene, Associate Vice President, Global QPPV, MSD
Wivina De Waele, Senior Director Europe, Global Markets Patient Safety, AstraZeneca
Roma Dhaia, Senior Manager, Regulatory Affairs, Geographic Expansion, Jazz Pharmaceuticals
Daniela Di Cosmo, Senior Safety Advisor, Global Safety, Ferring Pharmaceuticals
Lourdes Diaz, Pharmacovigilance Senior Manager, Shionogi SBV
Francesca Dickins, Advisor, Medicines Quality Organization, Eli Lilly
Steve Dingman, Vice President, Pharmacovigilance, Head of Safety, Merus NV
Moin Don, Lead, ISoP South Asia Chapter, ISoP
Updesh Dosanjh, Practice Leader, Pharmacovigilance Technology Solutions, IQVIA Inc.
Joan D'souza, Local QPPV, Independent PV Expert
Varun Dua, Founder and CEO, PV Analytica
Marjan Dzeparoski, RA and PV Manager, Bionika Pharmaceuticals
Ekaterina Edle von Dall'Armi, Local QPPV, Germany, GSK
Vicki Edwards, Vice President, Pharmacovigilance Excellence & International QPPV, AbbVie
James Eldridge, Senior Director, Global Drug Safety, Y-mAbs
John Ennion, Data, Digital & IT Business Partner for Global Regulatory Affairs, R&D Quality and Global Patient Safety, EMD Serono
Mirko Fedrigo, Head of Drug Safety Europe and Global PV Quality System, EU/UK QPPV, Italfarmaco
Mr Kevin Fetterman, Executive Director, Orbit By Feith Systems
Sebastian Fischer, Regulatory Strategy Principal, TUV SUD Product Service GmbH
Veronica Fjellstrom, Global Head, Pharmacovigilance and Patient Safety, Oncopeptides AB
Paraskevi Floroskoufi, CHC Regional PV Head, Europe and Eurasia, Opella Healthcare Group
Suzanne Foncin, Scientific Director, Safety Evaluation & Risk Management, GSK
Pierfrancesco Franco, Senior Director, Safety Solutions Lead, CMO, PRD, Pfizer
Antonella Fretta, Senior Director, Aggregate Reporting Team Lead, Pfizer
Shelley Gandhi, Partner, Eliquent Life Sciences
Stewart Geary, Global Safety Officer, Eisai
Irina Ghiorghiu, Global Lead Vendor Management, Opella Healthcare Group
Serban Ghiorghiu, Deputy Chief Medical Officer, AstraZeneca
Magda Godula, Director, Regional Safety Platform Lead, pfizer
Shay Goldstein, Senior Director, Global Safety Lead Oncology, Bristol Myers Squibb
Pedro Gomes, Global Director, Pharmacovigilance (PV) Quality Assurance Lead, MSD
Christos Goulas, Senior Manager, Safety Risk Lead (SRL), pfizer
Ilaria Grisoni, Executive Director, Head of International QPPV Office and EEA QPPV, Jazz Pharmaceuticals
Uwe Gudat, CMO, Biocon Biologics
Luis Guedes, Global Product Safety Science Lead, Sobi
Zeynep Gulder, Senior Manager, QPPV Office, Novartis
Israel Gutierrez, Chief Medical Officer, TLR Therapeutics Inc
Zoe Hamill, GPvP Inspector, MHRA
Pat Harding, Senior Director, International PV Operations (PSMF), Eli Lilly and Company
Linda Härmark, Director, Drug Safety Research Unit
Fabian Heisig, Chief Medical Officer, Senior Vice President, Head Global Drug Safety & QPPV, Grunenthal
Janni Hermansen, Director, Head of Global Safety Operations, Ferring Pharmaceuticals A/S
Dawn Hill, VP, Global Risk Management and REMS, Syneos Health
Peter Hjelmstrom, Director and Chief Executive Officer, Uppsala Monitoring Centre
Paul Hoericke, Global Procurement Category Lead Product Lifecycle Management, Bayer AG
Tanja Hoffman, Owner, Executive Consultant, Independent PV Expert
Jan Holzer, PV Innovation & Solutions Lead, CSL Behring
Annette Humes, Chief of Staff, Global Head of Safety Resource and Alliance Management, Roche
Stacy Hurt, Chief Patient Officer, Parexel International LLC
Tuula Ikonen, Head of Pharmacovigilance Department, EORTC
Zeshan Iqbal, Senior Director, Pharmacovigilance, ClinChoice Inc
Maximilian Jacobs, Head of Vendor Management, Pharmacovigilance, Bayer AG
Cheryl James, Team Lead, PV Global Safety Database, Cencora
Anjani Jha, CEO, Nextrove
Philip Jones, Senior Director, Disease Area Cluster Lead, CVMWH, Pfizer
Rafael Josupeit, EEA QPPV, Procter & Gamble
Corinne Jouquelet-Royer, Senior Vice President, Chief Safety Officer, Head of Patient Safety & Pharmacovigilance, Sanofi
Vineet Kacker, Managing Director and Global Technical Head, APCER Life Sciences
Mette Stie Kallesøe, Head of Pharmacovigilance, QPPV, Hansa Biopharma
Shahin Kauser, Leading Senior Scientific Assessor, MHRA
Elena Keller, Director, PV, RA, Quality and Medical Operations, Local QPPV, Ipsen Pharma GmbH
Karin Kempe, EU/UK QPPV, Karo Healthcare
Ranjana Khanna, Global Director, GVP, QA, R&D Quality, BeiGene
Jean Kilgour-Christie, Deputy EU QPPV Head, UK QPPV, Sandoz
Sven Kohler, Vice President, EU-QPPV and Head Regional Patient Safety and PV, Boehringer Ingelheim
Peter Kohut, Senior Director, Head of Pharmacovigilance, Alvotech
David Kolosic, Director, Safety Strategy, Veeva Systems
Anna Konczak, EU QPPV, Polpharma
Smruti Kothari, Associate Director, Global Patient Safety, Quality and Compliance, Regeneron
Malin Kreitz, Director, European Operations, Ultragenic Research & Technologies LLC
Marcin Kruk, Senior Director, Drug Safety Unit Regional Head, Europe, Africa & Middle East, Pfizer
Sergiy Kryvych, Senior Drug Safety Officer & Medical Advisor, Deputy Local Pharmacovigilance Responsible Person, Pfizer
Jürgen Kübler, Co-Chair, ASA Biopharm Safety Working Group
Thomas Kuckuk, Head, Pharmacovigilance Systems Management, Novartis
Marie-Laure Kürzinger, Head of Pharmacoepidemiology, General Medicine, Sanofi
Graeme Ladds, CEO, PharSafer
Vladimir Laguerre, Partner, Prudentia Group LLC
Amir Lahouegue, Director, Patient Safety & Cluster Lead, France & Benelux, AstraZeneca
Catherine Lambermont, Risk Management Head, Sanofi
Nick Larsen, Director Data, AI & Migrations, ProductLife Group
Jost Leemhuis, Patient Safety, Roche
Claudia Lehmann, Vice President, Head, Patient Safety & Pharmacovigilance Operations, Boehringer Ingelheim International
Rita Lobatto, Executive Director, Patient Safety & Pharmacovigilance, RP&L Consultancy
Han Ma, Senior Vice President, Chief Safety Officer, BeOne Medicines
Sujith Madhavan, Medical Director, Pharmacovigilance, Jazz Pharmaceuticals
Ryan Magee, Founder & Vice President of Engineering, IMPAQT Engineering
Asif Mahmood, Vice President, Medical Safety & Pharmacovigilance, AskBio
Balaji Malla, Head of Pharmacovigilance, EU & UK QPPV, Dr Reddys Laboratories Limited
Valentina Mancini, Senior Director, Pharmacovigilance, QPPV, Shionogi & TransCelerate
Monika Manske, Lead Quality Management, Viatris
Marcin Marciniak, Senior Director, Global Safety and PV Expert WHC, Gedeon Richter U.K. Ltd
Daniela Marcozzi, Head of Corporate Clinical Safety, Pharmacovigilance and R&D Compliance, EU & UK QPPV, Fidia farmaceutici spa
Anastazja Markowska, Director, Polish Society of Pharmacovigilance
Jonas Maselis, Head of Digital Technology Patient Safety, UCB
Jorgen Matz, Global Head, Pharmacovigilance & Clinical Quality, INSUD PHARMA
Adrian Maynier, Head of Safety Systems, UCB
Mansa Mbenga, Team Lead: Treatment & Care, KNCV Tuberculosis Foundation
Bruno Mendez, Global Head Pharmacovigilance Quality, SANOFI
Fabio Miceli, EU QPPV, Norgine
Danielle Middleton, Director, Safety Physician, Jazz Pharmaceuticals
Sanjeev Miglani, Founder and Director, AWINSA Life Sciences
Shadab Mohammed, Co-Founder and Safety SME, Ultragenic Research & Technologies LLC
Rania Mouchantaf, Executive Director, Health Canada
Marianne Mounir, Senior Global Auditor, Bayer
Céline Muffang, Director, Medical Safety and Benefit Risk Assessment, AskBio
Sutirtha Mukhopadhyay, Senior Associate Director, Senior Patient Safety Physician, Boehringer Ingelheim
George Mullens, Project Manager, Terrapinn Holdings Ltd
Raghu Murthy, Senior Director, Sophos IT Services
Milind Nadgouda, Director, Operations, RiverArk Limited
Yvonne Nanciu, Country Head, Pharmacovigilance, Deputy EU QPPV, Bayer
Dominic Nguyen-Van-Tam, Senior Pharmacovigilance Inspector, MHRA
Gavin Nichols, Chief Transformation Officer, Ergomed
M. Sylvain NICOLAS, Global Head, Safety Data Strategy and Data Management, SANOFI
Magnus Nord, Vice President, Global Patient Safety BioPharma, AstraZeneca
Kieran O'Donnell, Director, Independent PV Expert
Nadine O'Hare, Senior Director, Global Patient Safety, PV Intelligence, Regeneron
Attila Oláh, Vice President, Head, Global Patient Safety, EU-QPPV, Gedeon Richter Plc
Ann-Marie Orange, Chief Information Officer and Global Head of R&D, ArisGlobal
Bruce Palsulich, Strategic Client Executive, Oracle Health and Life Sciences
Shaloo Pandhi, Chief Medical Officer, Sandoz
Krupa Patel, Senior Safety Scientist, Global Patient Safety, Ipsen
Bina Patel, AVP, Pharmacovigilance Operations, Amgen
Teodora Perger, Visiting Lecturer, King's College London
Mark Perrott, Managing Partner, Axian Consulting ltd.
Malene Nyboe Persson, Specialist Safety Officer, Ferring Pharmaceuticals A/S
Catherine Pons, Affiliate Patient Safety Director, Roche
Elena Prokofyeva, Head of Drug Safety Unit, DG Post, FAMHP - Federal Agency for Medicines and Health Products in Belgium
Peter Psarologos, Senior QPPV, UBC
Rohit Pushparajan, Managing Director, Europe Life Science R&D Lead, Accenture
Natalia Quintana, Associate Director, GPV Performance Excellence, kyowa kirin
Humaira Qureshi, Arriello
Mr. Abdul Rahim, Founding Director, ALWIS Solutions Limited
Daria Giusi Rasà, Head of Corporate Pharmacovigilance, EU/UK QPPV, Alfasigma
Asad Rashid, VP, Safety & Pharmacovigilance, Syneos Health
Maria Jose Reneses, Senior Director, Deputy EU QPPV & Head of PSMF Team, Takeda
Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI
Lisa Riste, Research Fellow, NIHR Greater Manchester Patient Safety Centre, University of Manchester
Luisa Ritz-Cortes, Associate Director, Business Excellence & Strategy for Global Regulatory Affairs, R&D Quality and Global Patient Safety, Merck KGaA
Nathan Rivers, Associate Director, Medical Safety, Oncology, Jazz Pharmaceuticals
Hira Rizvi, Medical Safety Officer, Sanofi
Jonathon Romero, Principal Safety & Pharmacovigilance Ops Specialist, Syneos Health
Hadir Rostom, Independent PV Expert - Lecturer, Modern Sciences And Arts University
Radoslaw Rysiewski, Product Manager, Compliance and Oversight, roche
Zina Sadeq, Director, Regional PV and Alliance Management, UK QPPV, Amicus Therapeutics
Myriam Salem, Good Clinical Practice National Supervisor, Health Canada
Manon Sanz, Safety Project Officer (Gene and cell therapies), Généthon
Delphine Saragoussi, Head of Pharmacoepidemiology, Vaccines, Patient Safety & Pharmacovigilance, Sanofi
Monika Sarnecka, Associate Director, Clinical Data Management, MSD
Yvonne Schäfer, Head of Patient Safety and Pharmacovigilance Systems Business Solutions, Boehringer Ingelheim International
Rudi Scheerlinck, Global Program Safety Lead, Merck Healthcare Oncology
Reinhold Schilling, Head of Global Pharmacovigilance, EU QPPV, Wörwag Pharma
Ona Kinduryte Schorling, Vice President, Global Medical Safety, Lundbeck
Eveline Schurink, Vice President, Clinical Development, Patient Safety & Medical Affairs, Alvotech
Maurizio Sessa, Associate Professor, Pharmacovigilance and Pharmacoepidemiology, University of Copenhagen
Nikesh Shah, VP, Global Head, Drug Safety and PV, Indegene Inc.
Vedaant Shourie, Director, Professional Services, Pinnaxis
Saket Singh, Principal Director, EU PV Capability Lead (S&C/Tech/Ops), Accenture
Lucinda Smith, Chief Safety Product Officer • Product Management, ArisGlobal
Howard Snow, Vice President, Global Head of Pharmacovigilance, Sobi (Swedish Orphan Biovitrum)
Jens-Ulrich Stegmann, Senior Vice President, Head Clinical Safety and Pharmacovigilance, EU QPPV, GSK
Ada Stelmakiene, Head of Pharmacovigilance, Insuvia, UAB
Ariane Stollenwerk, Director, Head of Safety Central Europe & APAC, UCB
Johanna Strandell, Director, Patient Safety, Camurus AB
Marija Stupar, Senior Director, Head Safety & Benefit Risk, Opioids and Generics, Grünenthal GmbH
Amar Swaroop, Director, Global Lead, Customer Engagement Programmes, Viatris
Sarah Tarnowsky, PSMF Coordinator & Specialist Quality Management, Viatris
Stéphanie Tcherny-Lessenot, Global Head, Benefit-Risk Evaluation, Sanofi
Anders Thyme, Director, Pharmacovigilance, Ascendo
Everdina Tiemersma, Senior Epidemiologist, KNCV Tuberculosis Foundation
Phil Tregunno, Deputy Director, Patient Safety Monitoring, MHRA
Marco Tuccori, Associate Professor of Pharmacology, Department of Diagnostic & Public Health, University of Verona
Alina Tudor, Global Head, Medical Evaluation and ICSR Review, Kyowa Kirin International
Vivienne van de Walle, Medical Director, P.T. and R
Willemijn Van Der Spuij, Executive Director, International Patient Safety, Bristol Myers Squibb
Kristian van Kalmthout, Digital Health Consultant, KNCV Tuberculosis Foundation
Bert Van Leeuwen, Senior Director, Deputy QPPV, Astellas Pharma Europe BV
Mary Lynne van Poelgeest-Pomfret, President, World Federation for Incontinence and Pelvic Problems (WFIPP)
Job van Rest, Team Lead Digital Health Solutions, KNCV Tuberculosis Foundation
Brittany Vaucher, Associate Director, GRMSS Portfolio Mgmt, Incyte
Sarah Vaughan, Head of Vigilance Operations, MHRA
Deepa Venkataraman, Vice President, Head of Patient Safety and Pharmacovigilance, Corcept Therapeutics
Sriram Venkateswaran, Safety Data Science Director, Hoffmann la Roche Ltd
Sumit Verma, Director and President, Operations Management, CSPV, Soterius, Inc.
Michael von Forstner, Clinical Development Leader, Crearene AG
Nisha Vora, Safety Science Director, Global Patient Safety, Ipsen
Ivana Vranic, Director, Safety Risk Lead, Inflammation & Immunology, Pfizer
Sanjay Vyas, President,Global Head Safety & Logistics,Managing Director India, Parexel
Ryan Walker, Assistant Professor, Clinical Pharmacy, university of Birmingham
Samuel Wallis, Senior Director, Head of Case Management, Patient Safety, Bristol Myers Squibb
Dany Ward, Executive Director, Head of PV Ops & Global Risk Management, Jazz Pharmaceuticals
Aman Wasan, CEO, ArisGlobal
Rebecca Webb, Senior Director, Safety, Medical and Regulatory Quality, AbbVie
Heinz Weidenthaler, Senior Director, Safety Strategy Lead, BioNTech
Shanti Werther, Executive Director, Global Safety Head, Immunology Patient Safety, Biopharma, AstraZeneca
Robert Westphal, Digital Lead IT Pharma, Chief Medical Office, Bayer
Dieter Wetzel, Head of Medical Science, toclinco GmbH
Alan White, CEO, Arriello
Tina Wirstrom, Director, EU QPPV Office, Takeda
Sridhar Yeshamaina, Vice President, Global Patient Safety, Amneal Pharmaceuticals
Aya Zaghloul, Associate Director, GPS International Pharmacovigilance Operations, Eli Lilly and Company
Dimitrios Zampatis, Director, Product Patient Safety, Sandoz
Gyorgy Zorenyi, Senior Medical Director, Medical Safety, Jazz Pharmaceuticals
Get Involved At
World Drug Safety Congress
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events